Renaissance holds 5.52% stake in Utah Medical Products

Renaissance Technologies LLC and Renaissance Technologies Holdings Corporation report beneficial ownership of 175,814 shares of Utah Medical Products Inc. common stock, representing 5.52% of the class as of June 30, 2026.

Rhea-AI Filing Summary

Renaissance Technologies LLC and Renaissance Technologies Holdings Corporation report beneficial ownership of 175,814 shares of Utah Medical Products Inc. common stock, representing 5.52% of the class as of June 30, 2026. Both entities have sole voting and dispositive power over these shares, with no shared power reported. Certain funds managed by Renaissance Technologies LLC have the right to receive dividends and proceeds from the sale of these securities. The filing is signed by Brian Felczak in his capacities as Chief Financial Officer and Vice President on August 13, 2026.

Key Figures

Beneficial ownership: 175,814 shares Percent of class: 5.52% Sole voting power: 175,814 shares +1 more

4 metrics

Beneficial ownership 175,814 shares Common stock of Utah Medical Products Inc. as of June 30, 2026

Percent of class 5.52% Percentage of Utah Medical Products Inc. common stock beneficially owned

Sole voting power 175,814 shares Shares over which the filers have sole power to vote or direct the vote

Sole dispositive power 175,814 shares Shares over which the filers have sole power to dispose or direct disposition

Key Terms

beneficially owned, Sole Voting Power, dispositive power, Schedule 13G, +1 more

5 terms

beneficially owned financial

"Item 4. | Ownership (a) | Amount beneficially owned: 175814"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Sole Voting Power financial

"5 | Sole Voting Power 175,814.00 6 | Shared Voting Power 0.00"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

dispositive power financial

"Sole Dispositive Power 175,814.00 8 | Shared Dispositive Power 0.00"

Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

Schedule 13G regulatory

"Statement on , and all amendments thereto, with respect to the shares"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

Investment Company Act of 1940 regulatory

"shareholders of an investment company registered under the Investment Company Act of 1940"

A U.S. federal law that sets the rulebook for pooled investment vehicles such as mutual funds, exchange-traded funds and similar money managers, requiring them to register with regulators, disclose holdings and fees, limit conflicts of interest, and follow governance standards. It matters to investors because these protections and transparency rules act like a referee and scoreboard, helping people compare funds, trust that managers follow fair practices, and spot hidden costs or risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What percentage of UTMD does Renaissance Technologies report owning in this Schedule 13G/A?

Renaissance Technologies reports beneficial ownership of 5.52% of Utah Medical Products Inc. (UTMD) common stock. This corresponds to 175,814 shares as of June 30, 2026, giving the filer a reportable position above the 5% disclosure threshold.

How many UTMD shares are beneficially owned by Renaissance Technologies according to this filing?

The filing reports beneficial ownership of 175,814 shares of Utah Medical Products Inc. (UTMD) common stock. These shares are subject to sole voting and sole dispositive power, with no shared voting or dispositive authority reported by the filers.

Who are the reporting persons in the UTMD Schedule 13G/A filing?

The reporting persons are Renaissance Technologies LLC and Renaissance Technologies Holdings Corporation. Both are organized in Delaware and report the same 175,814 shares and 5.52% stake in Utah Medical Products Inc. (UTMD) common stock.

What voting and dispositive powers over UTMD shares does Renaissance Technologies report?

Renaissance reports sole power to vote and dispose of 175,814 UTMD shares. It reports zero shared voting power and zero shared dispositive power, indicating all reported authority over these shares is held on a sole basis by the filers.

Which entities benefit economically from the UTMD shares held by Renaissance Technologies?

The filing states that certain funds managed by Renaissance Technologies LLC have the right to receive dividends and sale proceeds from the UTMD shares. This indicates economic benefits flow to those funds, while voting and dispositive power are reported by the filers.

As of what date is the UTMD ownership information by Renaissance Technologies reported?

The ownership information is reported as of June 30, 2026. The document is later signed on August 13, 2026, confirming the 5.52% beneficial ownership and 175,814 UTMD shares at the earlier reference date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/13/2026 - 04:26 PM Accepted by SEC EDGAR 08/13/2026 - 04:25 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 8)

UTAH MEDICAL PRODUCTS INC

(Name of Issuer)

Common stock, $0.01 par value

(Title of Class of Securities)

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP No.

1

Names of Reporting Persons

Renaissance Technologies LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 175,814.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 175,814.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

175,814.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.52 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

CUSIP No.

1

Names of Reporting Persons

Renaissance Technologies Holdings Corporation

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 175,814.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 175,814.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

175,814.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.52 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

Item 1.
(a)	Name of issuer: UTAH MEDICAL PRODUCTS INC
(b)	Address of issuer's principal executive offices: 7043 S 300 WEST, MIDVALE, UT 84047
Item 2.
(a)	Name of person filing: This Schedule 13G is being filed by Renaissance Technologies LLC ("RTC") and Renaissance Technologies Holdings Corporation ("RTHC").
(b)	Address or principal business office or, if none, residence: 520 Madison Avenue, New York, New York 10022
(c)	Citizenship: RTC is a Delaware limited liability company, and RTHC is a Delaware corporation.
(d)	Title of class of securities: Common stock, $0.01 par value
(e)	CUSIP No.:
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 175814
(b)	Percent of class: 5.52 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 175814
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 175814
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. Certain funds managed by RTC have the right to receive dividends and proceeds from the sale of the securities which are the subject of this report.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Renaissance Technologies LLC

Signature:	Brian Felczak
Name/Title:	Chief Financial Officer
Date:	08/13/2026

Renaissance Technologies Holdings Corporation

Signature:	Brian Felczak
Name/Title:	Vice President
Date:	08/13/2026

Exhibit Information

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, each of the undersigned agrees to the filing on behalf of each of a Statement on Schedule 13G, and all amendments thereto, with respect to the shares of Common stock, $0.01 par value of UTAH MEDICAL PRODUCTS INC.